FDA approves Ziagen AIDS drug amid life threatening risk
The FDA approved Glaxo Wellcome Ziagen abacavir for use in multidrug AIDS cocktails while warning of a rare but life threatening hypersensitivity reaction. About 5 percent of patients may react, typically within six weeks, prompting immediate stop and medical advice. Ziagen will be in pharmacies next month with a yearly cost of 3540 dollars, priced lower than a new once a day protease inhibitor option.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
Glaxo Wellcome Inc
Glaxo
FDA
Heidi Jolson
Jolson
Lynn Smiley
Yucca Mountain Nuclear Waste Site Gains Momentum
Energy Department findings show no show stoppers for burying 80,000 tons of spent reactor fuel at Yucca Mountain Nevada. Interim report cites 15 years of geology research and says safety standards can be met, with final decision due in 2001 and potential availability not before 2010.
MENTIONED IN THIS ARTICLE
Washington
Desert Rock
Nevada
Energy Department
Energy
Bill Richardson
Yucca Mountain
Las Vegas
Richardson
Congress
Mary Olsen
Nuclear Information and Resources Service
Government probes safety of 900000 infant car seats
Government investigators examine safety issues in Cosco Arriva Turn About seats and Kolcraft Infant Rider models from 1995 to 1998 after 82 complaints of unlatching handles, 11 ejections, and injuries. About 460000 Cosco and 415000 Kolcraft seats are affected. Evenflo had a prior recall of 800000 seats.
MENTIONED IN THIS ARTICLE
Washington
Arriva
Cosco Inc
Kolcraft Enterprises
National Highway Traffic Safety Administration
Cosco
Kolcraft
The
Safety Agency
John Reynolds
Evenflo Co
Also Mentioned on This Page
Feds
Ziagen
RCA
America
RCA Direct
Zenith
Aztbaaw
Narge TV
MTS
SAP
Naughty
Nice
N. Grandview
Odessa
G.R. Albertson
D.O
D.W. Davison
M.D
Charles Eo
Andrews
Maxima Plush
SERTA
Posture Premier
Duchess
Ashion
AnDrews Hwy
Midland
W. Illinois